- Home
- IVVD vs GRVY Comparison
IVVD vs GRVY Comparison
Compare IVVD & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVVD | GRVY |
|---|---|---|
| Founded | 2020 | 2000 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 437.1M | 399.1M |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | IVVD | GRVY |
|---|---|---|
| Price | $1.72 | $60.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.75 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 20.7K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $53,426,000.00 | N/A |
| Revenue This Year | $143.48 | N/A |
| Revenue Next Year | $25.40 | N/A |
| P/E Ratio | ★ N/A | $8.05 |
| Revenue Growth | ★ 110.47 | N/A |
| 52 Week Low | $0.46 | $54.25 |
| 52 Week High | $3.07 | $74.75 |
Technical Indicators
Market Signals| Indicator | IVVD | GRVY |
|---|---|---|
| Relative Strength Index (RSI) | 51.65 | 37.28 |
| Support Level | $1.41 | $55.89 |
| Resistance Level | $2.01 | $65.27 |
| Average True Range (ATR) | 0.11 | 2.19 |
| MACD | 0.04 | -0.54 |
| Stochastic Oscillator | 57.32 | 10.03 |
Price Performance
Historical ComparisonAbout IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.